Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Americas Brachytherapy Americas Brachytherapy
The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
European Pre-clinical Imaging Devices Market European Pre-clinical Imaging Devices Market
The European Pre-Clinical Imaging Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “European Pre-Clinical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the European Pre-Clinical Imaging Devices Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European Pre-Clinical Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market.  
Upcoming
European Proton Radiotherapy Systems Market European Proton Radiotherapy Systems Market
The European Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $82.1 million in 2013 and expected to be $95.0 million by 2018, growing at a CAGR of 3.0%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc.
Upcoming
North American Pre-clinical Imaging Devices Market North American Pre-clinical Imaging Devices Market
The North American Pre-Clinical Imaging Devices Market, mainly driven by aging population, technological advancements, low cost of the treatment, and increasing prevalence to various diseases such as cancer and heart related disorders. The report “North American Pre-Clinical Imaging Devices Market forecast, 2008-2018 “analyzes the market of devices majorly on the basis of technologies. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report North American Pre-Clinical Imaging Devices Market also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
European Non-Knowledge based Clinical decision support systems (CDSS) European Non-Knowledge based Clinical decision support systems (CDSS)
The European non-knowledge based clinical decision support systems (CDSS) market was estimated at $3 million in 2012, and is expected to reach $3.4 million by 2018, at a CAGR of 2.2%.The non-knowledge based CDSS market can be segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players are also considered in this report.
Upcoming
Asian Non-Knowledge based Clinical decision support systems (CDSS) Asian Non-Knowledge based Clinical decision support systems (CDSS)
The Asian non-knowledge based CDSS market was valued at $3 million in 2012, and is projected to reach $3.4 million by 2018, at a CAGR of 2.4%.The non-knowledge based CDSS market is segmented by geography, application, technology, product, and end-user. Deep dive analysis of key market players have also been considered in this report.
Upcoming
Asian Proton Radiotherapy Systems Market Asian Proton Radiotherapy Systems Market
The Asian Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $32.7 million in 2013 and expected to be $46.6 million by 2018, growing at a CAGR of 7.4%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc.
Upcoming
North American Polysomnography (PSG) Device North American Polysomnography (PSG) Device
The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $1.3 billion in 2013 and is expected to reach a value of $2.5 billion in 2018, with a CAGR of 14.7% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
North American E-Prescribing (e-Rx) North American E-Prescribing (e-Rx)
The North American E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $84.43 million in 2013 and expected to be $328.14 million by 2018, growing at a CAGR of 31.2% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.)
Upcoming
European BioProduction Market European BioProduction Market
The European BioProduction Market, mainly driven by increasing in-vitro research activities, increasing demand for vaccines and cellular medicine. The report “European BioProduction Market forecast, 2008-2018 “analyzes the market by 5 main segments such as tissue engineering, cell culture, protein engineering, biomaterials, and micro-reactor. Geographically, the European BioProduction Market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report European BioProduction Market  also provides an extensive competitive landscaping of companies operating in this market.
Upcoming
European E-Prescribing (e-Rx) European E-Prescribing (e-Rx)
The European E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $163.62 million in 2013 and expected to be $468.0 million by 2018, growing at a CAGR of 23.4% from 2013 to 2018. E-Prescribing (e-Rx) systems  market  segmentation segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.)
Upcoming
Asian E-Prescribing (e-Rx) Asian E-Prescribing (e-Rx)
The Asian E-Prescribing (e-Rx), mainly driven by growing popularity of e-priscripttion, was pegged at $71.49  million in 2013 and expected to be $232.22 million by 2018, growing at a CAGR of 26% from 2013 to 2018. E-Prescribing (e-Rx) systems market segmentation by products (Stand-alone and integrated), deployment modes( Licensed(On-premise, Web-hosted, Cloud hosted), usage mode(PC-based and Hand Held), components( Hardware, Software and Services), end users ( Hospitals and Office based physicians) , and geography. The major companies operating in E-Prescribing (e-Rx), market and extensively covered in the report are Cerner Corporation (U.S.), Allscripts (U.S), Quality Systems Inc. (U.S.), Emdeon (U.S.), and Athenahealth (U.S.), eclinical Works(U.S.), Practice Fusion (U.S.)
Upcoming
European Polysomnography (PSG) Device European Polysomnography (PSG) Device
The European Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $526.2 million in 2013 and is expected to reach a value of $1.0 billion in 2018, with a CAGR of 14.2% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
Asian Polysomnography (PSG) Device Asian Polysomnography (PSG) Device
The Asian Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA). The market is clinched at $292.7 million in 2013 and is expected to reach a value of $611.3 million in 2018, with a CAGR of 15.9% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
North American Ophthalmology Diagnostic and Monitoring Devices North American Ophthalmology Diagnostic and Monitoring Devices
The North American market for ophthalmology diagnostic and monitoring devices was valued at $675.7 million in 2013 expected to be growing at a CAGR of 4.4% from 2013 to 2018. ophthalmology diagnostic and monitoring devices can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.  
Upcoming
European Ophthalmology Diagnostic and Monitoring Devices European Ophthalmology Diagnostic and Monitoring Devices
Europe has been considered as the second largest market in ophthalmology surgery devices, with 25.41% of the market share, which is expected to grow at a CAGR of 3.69% from 2012 to 2018. The European ophthalmology surgery devices report offers a comprehensive analysis of the key market drivers, restraints, and upcoming opportunities. It also focuses on the current market trends and provides key market profiles of companies that thrive in this market.
Upcoming
Europe Hematology Europe Hematology
Europe holds second largest market position after North America. Germany commanded the largest share 20% of the Europe hematology market at an estimated $272.8 million in 2013 and is expected to reach $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The report “European Hematology Market forecast for 2018 “analyzes the market by 2 segments such as hematology reagents and hematology instruments.
Upcoming
North American Positive Airway Pressure (PAP) North American Positive Airway Pressure (PAP)
The North American Polysomnography (PSG) Devices market has gained tremendous importance owing to the large patient pool for Obstructive Sleep Apnea (OSA) as it forms the first line of treatment used for Sleep Apnea. The market is clinched at $2.7 billion in 2013 and is expected to reach a value of $6.0 billion in 2018, with a CAGR of 17.23 from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Upcoming
North America Hematology North America Hematology
North America commanded the largest share 41.75% of the Global hematology market at an estimated $1810.4 million in 2013 and are expected to reach $2479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Hematology Market forecast for 2018 “analyzes the market by 2 segments such as reagents and instruments.
Upcoming
North American Vendor Neutral Archive (VNA) North American Vendor Neutral Archive (VNA)
The North American vendor neutral archive market was valued at $103.9 million in 2013, which is expected to grow at a CAGR of 14.4% during the forecast period from 2014 to 2019. This market can be segmented on the basis of geographies, products, end-users, companies, and macro indicators. A DeepDive analysis of the top players of this market has been included in this report.
Upcoming
2983 reports | Show
Connect With Us
US/CAN : +1-888-502-0539